Last updated on May 2019

A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)

Brief description of study

The primary objective of this study is to examine the effect of Levodopa-Carbidopa Intestinal Gel (LCIG) relative to that of OMT on non-motor symptoms associated with Parkinson's disease (PD).

Clinical Study Identifier: NCT02549092

Find a site near you

Start Over

Parkinson's and Movement /ID# 161596

Fountain Valley, CA United States
  Connect »